{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:26:09Z","timestamp":1700526369415},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Development of pleural effusion (PE) following CABG is common. Post-CABG PE are divided into early- (within 30 days of surgery) and delayed-onset (30 days\u20131 year) which are likely due to distinct pathological processes. Some experts suggest asbestos exposure may confer an independent risk for late-onset post-CABG PE, however no large studies have explored this potential association.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Research question<\/jats:title>\n                <jats:p>To explore possible association between asbestos exposure and post-CABG PE using routine data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All patients who underwent CABG 01\/04\/2013\u201331\/03\/2018 were identified from the Hospital Episode Statistics (HES) Database. This England-wide population was evaluated for evidence of asbestos exposure, pleural plaques or asbestosis and a diagnosis of PE or PE-related procedure from 30 days to 1 year post-CABG. Patients with evidence of PE three months prior to CABG were excluded, as were patients with a new mesothelioma diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>68,150 patients were identified, of whom 1,003 (1%) were asbestos exposed and 2,377 (3%) developed late-onset PE. After adjusting for demographic data, Index of Multiple Deprivation and Charlson Co-morbidity Index, asbestos exposed patients had increased odds of PE diagnosis or related procedure such as thoracentesis or drainage (OR 1.35, 95% CI 1.03\u20131.76, p\u2009=\u20090.04). In those with evidence of PE requiring procedure alone, the adjusted OR was 1.66 (95% CI 1.14\u20132.40, p\u2009=\u20090.01). Additional subgroup analysis of the 518 patients coded for pleural plaques and asbestosis alone revealed an adjusted OR of post-CABG PE requiring a procedure of 2.16 (95% CI 1.38\u20133.37, p\u2009=\u20090.002).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Interpretation<\/jats:title>\n                <jats:p>This large-scale study demonstrates prior asbestos exposure is associated with modestly increased risk of post-CABG PE development. The risk association appears higher in patients with assigned clinical codes indicative of radiological evidence of asbestos exposure (pleural plaques or asbestosis). This association may fit with a possible inflammatory co-pathogenesis, with asbestos exposure \u2018priming\u2019 the pleura resulting in greater propensity for PE evolution following the physiological insult of CABG surgery. Further work, including prospective studies and clinicopathological correlation are suggested to explore this further.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02555-9","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T12:02:29Z","timestamp":1692619349000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does previous asbestos exposure increase the risk of a post coronary artery bypass graft (CABG) pleural effusion \u2013 a routine data study?"],"prefix":"10.1186","volume":"23","author":[{"given":"Hugh","family":"Welch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Pufulete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaldo","family":"Dimagli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"issue":"1","key":"2555_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1378\/chest.94.1.68","volume":"94","author":"MH Kollef","year":"1988","unstructured":"Kollef MH, Peller T, Knodel MA. Hal Cragun, delayed Pleuropulmonary Complications following coronary artery revascularization with the Internal Mammary Artery. Chest. 1988;94(1):68\u201371.","journal-title":"Chest"},{"issue":"4","key":"2555_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/00063198-200207000-00011","volume":"8","author":"RW Light","year":"2002","unstructured":"Light RW. Pleural effusions after coronary artery bypass graft surgery. Curr Opin Pulm Med. 2002;8(4):308\u201311.","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"2555_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0003-4975(90)91129-Y","volume":"50","author":"D Hurlbut","year":"1990","unstructured":"Hurlbut D, Lee Myers M, Lefcoe M, Goldbach M. Pleuropulmonary morbidity: Internal thoracic artery versus saphenous vein. Ann Thorac Surg. 1990;50(6):959\u201364.","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"2555_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.7326\/0003-4819-130-11-199906010-00004","volume":"130","author":"RW Light","year":"1999","unstructured":"Light RW, Rogers JT, Cheng D, Rodriguez RM. Large pleural effusions occurring after coronary artery bypass grafting. Cardiovascular surgery associates, PC. Ann Intern Med. 1999;130(11):891\u20136.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2555_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ccm.2006.01.007","volume":"27","author":"J Heidecker","year":"2006","unstructured":"Heidecker J, Sahn SA. The spectrum of pleural effusions after coronary artery bypass grafting surgery. Clin Chest Med. 2006;27(2):267\u201383.","journal-title":"Clin Chest Med"},{"issue":"17","key":"2555_CR6","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1001\/archinte.160.17.2665","volume":"160","author":"RT Sadikot","year":"2000","unstructured":"Sadikot RT, Rogers JT, Cheng D-s, Moyers P, Rodriguez M, Light RW. f.t.C.S.A. PC, Pleural Fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery. Arch Intern Med. 2000;160(17):2665\u20138.","journal-title":"Arch Intern Med"},{"issue":"7","key":"2555_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ehj.2004.02.002","volume":"25","author":"B Maisch","year":"2004","unstructured":"Maisch B, Seferovi\u0107 PM, Risti\u0107 AD, Erbel R, Rienm\u00fcller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH, Priori SG, Alonso Garcia MA, Blanc J-J, Budaj A, Cowie M, Dean V, Deckers J, Fernandez Burgos E, Lekakis J, Lindahl B, Mazzotta G, Moraies J, Oto A, Smiseth OA, Mazzotta G, Acar J, Arbustini E, Becker AE, Chiaranda G, Hasin Y, Jenni R, Klein W, Lang I, L\u00fcscher TF, Pinto FJ, Shabetai R, Simoons ML, Soler Soler J, Spodick DH. .f.P.G. Task Force members, Document Reviewers, Guidelines on the diagnosis and management of Pericardial Diseases Executive Summary: the Task Force on the diagnosis and management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2004;25(7):587\u2013610.","journal-title":"Eur Heart J"},{"key":"2555_CR8","doi-asserted-by":"crossref","unstructured":"Chibante AM, Vaz MC, Vargas FS. [IL-6 anti-inflammatory activity in pleural effusion post-coronary artery bypass graft surgery] Rev Port Pneumol, 2007. 13(3): p.\u00a0319 \u2013 34.","DOI":"10.1016\/S2173-5115(07)70338-X"},{"issue":"4","key":"2555_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0873-2159(15)30445-1","volume":"12","author":"AM Chibante","year":"2006","unstructured":"Chibante AM, Vaz MA, Suso FV. The proliferative cytokines TGF-beta and VEGF in pleural effusions post-coronary artery bypass graft. Rev Port Pneumol. 2006;12(4):359\u201367.","journal-title":"Rev Port Pneumol"},{"issue":"4935","key":"2555_CR10","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246(4935):1306\u20139.","journal-title":"Science"},{"issue":"3","key":"2555_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1378\/chest.119.3.795","volume":"119","author":"YCG Lee","year":"2001","unstructured":"Lee YCG, McDonald EC, Nesbitt JC, Vaz MAC, Ely KA, Light RW, Thompson PJ. Symptomatic persistent post-coronary artery bypass graft pleural Effusions requiring operative treatment: clinical and histologic features. Chest. 2001;119(3):795\u2013800.","journal-title":"Chest"},{"issue":"1","key":"2555_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radcr.2021.09.050","volume":"17","author":"T Touma","year":"2022","unstructured":"Touma T, Taira R, Makida T, Oshiro K, Miyara T, Taba Y. Marked ventilation impairment due to progression of diffuse pleural thickening after cardiac surgery. Radiol Case Rep. 2022;17(1):1\u20134.","journal-title":"Radiol Case Rep"},{"key":"2555_CR13","doi-asserted-by":"crossref","unstructured":"A review of human carcinogens\u2014Part C: metals, arsenic, dusts, and fibres The Lancet Oncology, 2009. 10(5): p.\u00a0453\u2013454.","DOI":"10.1016\/S1470-2045(09)70134-2"},{"issue":"4","key":"2555_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1440-1843.2004.00630.x","volume":"9","author":"JT Huggins","year":"2004","unstructured":"Huggins JT, Sahn SA. Causes and management of pleural fibrosis. Respirology. 2004;9(4):441\u20137.","journal-title":"Respirology"},{"issue":"2","key":"2555_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1179\/2049396714Y.0000000104","volume":"21","author":"M Evison","year":"2015","unstructured":"Evison M, Barber P. Diffuse pleural thickening following heart failure-related pleural effusions in an asbestos exposed patient. Int J Occup Environ Health. 2015;21(2):169\u201371.","journal-title":"Int J Occup Environ Health"},{"issue":"12","key":"2555_CR16","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1183\/09031936.97.10122898","volume":"10","author":"C Knoop","year":"1997","unstructured":"Knoop C, Mairesse M, Lenclud C, Gevenois P, De Vuyst P. Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship? Eur Respir J. 1997;10(12):2898\u2013901.","journal-title":"Eur Respir J"},{"issue":"3 Pt 1","key":"2555_CR17","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1164\/ajrccm.154.3.8810620","volume":"154","author":"ST Kee","year":"1996","unstructured":"Kee ST, Gamsu G, Blanc P. Causes of pulmonary impairment in asbestos-exposed individuals with diffuse pleural thickening. Am J Respir Crit Care Med. 1996;154(3 Pt 1):789\u201393.","journal-title":"Am J Respir Crit Care Med"},{"key":"2555_CR18","unstructured":"[cited 2022 25\/01\/2022]. ; Available from: https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics."},{"issue":"2","key":"2555_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s40273-015-0326-3","volume":"34","author":"JC Thorn","year":"2016","unstructured":"Thorn JC, Turner E, Hounsome L, Walsh E, Donovan JL, Verne J, Neal DE, Hamdy FC, Martin RM, Noble SM. Validation of the Hospital Episode Statistics Outpatient dataset in England. PharmacoEconomics. 2016;34(2):161\u20138.","journal-title":"PharmacoEconomics"},{"key":"2555_CR20","unstructured":"World Health O. ICD-10: international statistical classification of diseases and related health problems : tenth revision. World Health Organization: Geneva; 2004."},{"issue":"3","key":"2555_CR21","doi-asserted-by":"publisher","first-page":"e023316","DOI":"10.1136\/bmjopen-2018-023316","volume":"9","author":"G Bortolussi","year":"2019","unstructured":"Bortolussi G, McNulty D, Waheed H, Mawhinney JA, Freemantle N, Pagano D. Identifying cardiac surgery operations in hospital episode statistics administrative database, with an OPCS-based classification of procedures, validated against clinical data. BMJ Open. 2019;9(3):e023316.","journal-title":"BMJ Open"},{"issue":"7497","key":"2555_CR22","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/bmj.330.7497.960","volume":"330","author":"M Mamdani","year":"2005","unstructured":"Mamdani M, Sykora K, Li P, Normand S-LT, Streiner DL, Austin PC, Rochon PA, Anderson GM. Reader\u2019s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ. 2005;330(7497):960\u20132.","journal-title":"BMJ"},{"issue":"3","key":"2555_CR23","doi-asserted-by":"publisher","first-page":"e0172814","DOI":"10.1371\/journal.pone.0172814","volume":"12","author":"C Maringe","year":"2017","unstructured":"Maringe C, Fowler H, Rachet B, Luque-Fernandez MA. Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities. PLoS ONE. 2017;12(3):e0172814.","journal-title":"PLoS ONE"},{"issue":"6","key":"2555_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.mcna.2011.08.005","volume":"95","author":"RW Light","year":"2011","unstructured":"Light RW. Pleural effusions. Med Clin North Am. 2011;95(6):1055\u201370.","journal-title":"Med Clin North Am"},{"key":"2555_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijcard.2018.05.028","volume":"270","author":"FA Saraiva","year":"2018","unstructured":"Saraiva FA, Girerd N, Cerqueira RJ, Ferreira JP, Vilas-Boas N, Pinho P, Barros A, Amorim MJ, Louren\u00e7o AP. Leite-Moreira, Survival after bilateral internal mammary artery in coronary artery bypass grafting: are women at risk?. Int J Cardiol. 2018;270:89\u201395.","journal-title":"Int J Cardiol"},{"issue":"3","key":"2555_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0889-8537(03)00048-8","volume":"21","author":"CG Koch","year":"2003","unstructured":"Koch CG, Nussmeier NA. Gender and cardiac surgery. Anesthesiol Clin North Am. 2003;21(3):675\u201389.","journal-title":"Anesthesiol Clin North Am"},{"issue":"6","key":"2555_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1378\/chest.09-0689","volume":"136","author":"M Labidi","year":"2009","unstructured":"Labidi M, Baillot R, Dionne B, Lacasse Y, Maltais F, Boulet LP. Pleural effusions following cardiac surgery: prevalence, risk factors, and clinical features. Chest. 2009;136(6):1604\u201311.","journal-title":"Chest"},{"issue":"1","key":"2555_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00380-006-0930-4","volume":"22","author":"J-C Charniot","year":"2007","unstructured":"Charniot J-C, Zerhouni K, Kambouchner M, Martinod E, Vignat N, Azorin J, Gandjbakhch I, Artigou J-Y. Persistent symptomatic pleural effusion following coronary bypass surgery: clinical and histologic features, and treatment. Heart Vessels. 2007;22(1):16\u201320.","journal-title":"Heart Vessels"},{"issue":"1","key":"2555_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1440-1843.2006.00972.x","volume":"12","author":"MC Peng","year":"2007","unstructured":"Peng MC, Hou CJ, Li JY, Hu PY, Chen CY. Prevalence of symptomatic large pleural effusions first diagnosed more than 30 days after coronary artery bypass graft surgery. Respirology. 2007;12(1):122\u20136.","journal-title":"Respirology"},{"issue":"1","key":"2555_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12940-018-0431-9","volume":"17","author":"R Xu","year":"2018","unstructured":"Xu R, Barg FK, Emmett EA, Wiebe DJ, Hwang WT. Association between mesothelioma and non-occupational asbestos exposure: systematic review and meta-analysis. Environ Health. 2018;17(1):90.","journal-title":"Environ Health"},{"issue":"5","key":"2555_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5694\/mja11.10125","volume":"195","author":"NJ Olsen","year":"2011","unstructured":"Olsen NJ, Franklin PJ, Reid A, de Klerk NH, Threlfall TJ, Shilkin K, Musk B. Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation. Med J Aust. 2011;195(5):271\u20134.","journal-title":"Med J Aust"},{"key":"2555_CR32","doi-asserted-by":"crossref","unstructured":"BTS statement on malignant mesothelioma in the UK, 2007. Thorax, 2007. 62(Suppl 2): p. ii1\u2013ii19.","DOI":"10.1136\/thx.2007.087619"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02555-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02555-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02555-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T21:05:56Z","timestamp":1700514356000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02555-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2555"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02555-9","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hospital Episode Statistics (HES) data is not obtained directly from the patients but from hospital provider systems via the Secondary Uses Service (SUS) thus consent for anonymised data usage is not required. HES data was handled and analysed in accordance with NHS HES protocols. Ethical approval is not required for use of non-identifiable HES data. See HES analysis guide for full details: ExternalRef removed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"307"}}